Confirmatory interleukin-1 receptor antagonist trial in severe sepsisSteven M. Opal, Michael G. Seneff, Eric J. DeMaria et al.|Critical Care Medicine|1997Cited by 863
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES StudyKonrad Reinhart, Martin Kaul, Jean‐Louis Vincent et al.|Critical Care Medicine|2001Cited by 261